Infliximab: lymphomas and severe hepatitis.
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008223:Lymphoma / Q000139:chemically induced*
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents